Literature DB >> 14216146

AGRANULOCYTOSIS ASSOCIATED WITH IMIPRAMINE (TOFRANIL).

S I HNATKO, J H STIRRAT, J VERCHOMIN, C G RAMSEY.   

Abstract

Entities:  

Keywords:  AGRANULOCYTOSIS; BLOOD CHEMICAL ANALYSIS; DEATH; DRUG THERAPY; IMIPRAMINE; LEUKOCYTE COUNT; PHENOTHIAZINES; TOXICOLOGIC REPORT

Mesh：

Substances：

Year:  1965        PMID： 14216146      PMCID： PMC1927885     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  3 in total

1.  Agranulocytosis associated with tofranil.

Authors:  H L GOODMAN
Journal:  Ann Intern Med       Date:  1961-08       Impact factor: 25.391

2.  Agranulocytosis following use of imipramine hydrochloride (tofranil).

Authors:  P A ROTHENBERG; C HALL
Journal:  Am J Psychiatry       Date:  1960-03       Impact factor: 18.112

3.  Agranulocytosis due to imipramine (tofranil).

Authors:  C E BIRD
Journal:  Can Med Assoc J       Date:  1960-05-14       Impact factor: 8.262
  3 in total
  3 in total

1.  Irreversible protein binding of 14C-imipramine in rats in vivo.

Authors:  H Kappus
Journal:  Arch Toxicol       Date:  1976-12-23       Impact factor: 5.153

2.  The treatment of acute and chronic staphylococcal osteomyelitis and soft tissue infections with lincomycin.

Authors:  S I Hnatko
Journal:  Can Med Assoc J       Date:  1967-09-09       Impact factor: 8.262

Review 3.  Risks and benefits of drugs used in the management of the hyperactive child.

Authors:  A M Fox; M J Rieder
Journal:  Drug Saf       Date:  1993-07       Impact factor: 5.606
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.